Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
Launched by UNIVERSITY OF MICHIGAN · Mar 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how personalized text messages can help young adults become more physically active and manage their weight better. The researchers want to find out if sending messages that are tailored to each person’s needs and preferences works better than sending random messages or no messages at all. Participants will receive education on how to stay active and will wear a fitness tracker for a year to monitor their steps and weight.
To join the study, participants should be between 18 and 30 years old, own a smartphone, and be willing to wear a fitness tracker most of the day for 12 months. They should also be able to read and understand English. Over the course of the trial, participants will be divided into three groups: one will receive personalized messages, another will get random messages, and the third won’t receive any motivational messages. The goal is to see if those getting personalized messages are more active and experience less weight gain compared to the others. This study aims to help improve health and encourage more young adults to stay active.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • own an iPhone or Android smartphone that they would be willing to download the Fitbit app onto and sync with a Fitbit tracker and a custom, AIM app
- • willing to wear a Fitbit tracker almost continually (23.5 hours/day) for a 12- month period of time
- • free of visual impairment that would interfere with the receipt of text messages on their phone
- • capable of reading, speaking and understanding English and of giving informed consent
- • willing to complete a full 18-month study protocol
- Exclusion Criteria:
- • self-report sufficient aerobic activity to meet 2018 Physical Activity Guidelines for American adults
- • research-grade accelerometer records sufficient aerobic physical activity to meet 2018 Physical Activity Guidelines for American adults
- • living outside the continental US
- • one or more contraindications to physical activity
- • require an assistive device for mobility or have any other condition that may limit or prevent participation in moderate-intensity physical activity
- • pregnant or planning to become pregnant within the next 12 months
- • prior diagnosis of cancer, cardiovascular disease, diabetes or metabolic syndrome
- • concurrent participation in another research study involving physical activity or weight loss
- • planning to have surgery or relocate outside the continental US within the next year.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
University Park, Pennsylvania, United States
Patients applied
Trial Officials
David E Conroy, PhD
Principal Investigator
University of Michigan
Constantino M Lagoa, PhD
Principal Investigator
The Pennsylvania State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials